137 related articles for article (PubMed ID: 1405768)
1. Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period.
Gertz MA; Kyle RA; Thibodeau SN
Mayo Clin Proc; 1992 May; 67(5):428-40. PubMed ID: 1405768
[TBL] [Abstract][Full Text] [Related]
2. The premortem recognition of systemic senile amyloidosis with cardiac involvement.
Kyle RA; Spittell PC; Gertz MA; Li CY; Edwards WD; Olson LJ; Thibodeau SN
Am J Med; 1996 Oct; 101(4):395-400. PubMed ID: 8873510
[TBL] [Abstract][Full Text] [Related]
3. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis.
Fine NM; Arruda-Olson AM; Dispenzieri A; Zeldenrust SR; Gertz MA; Kyle RA; Swiecicki PL; Scott CG; Grogan M
Am J Cardiol; 2014 May; 113(10):1723-7. PubMed ID: 24698461
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation.
Banerjee D; Roeker LE; Grogan M; Swiecicki P; Poterucha J; Heimbach J; Zeldenrust S; Gertz M; Edwards B; Daly R; Klarich KW; Dispenzieri A
Prog Transplant; 2017 Sep; 27(3):246-250. PubMed ID: 29187090
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive risk stratification of patients with transthyretin amyloidosis.
Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
[TBL] [Abstract][Full Text] [Related]
6. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
Coutinho MC; Cortez-Dias N; Cantinho G; Conceição I; Oliveira A; Bordalo e Sá A; Gonçalves S; Almeida AG; de Carvalho M; Diogo AN
Circ Cardiovasc Imaging; 2013 Sep; 6(5):627-36. PubMed ID: 23833285
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.
Gallego-Delgado M; González-López E; Muñoz-Beamud F; Buades J; Galán L; Muñoz-Blanco JL; Sánchez-González J; Ibáñez B; Mirelis JG; García-Pavía P
Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):923-930. PubMed ID: 27291669
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy.
Rajkumar SV; Gertz MA; Kyle RA
Am J Med; 1998 Mar; 104(3):232-7. PubMed ID: 9552085
[TBL] [Abstract][Full Text] [Related]
9. Familial amyloidosis in a large Spanish kindred resulting from a D38V mutation in the transthyretin gene.
Augustin S; Llige D; Andreu A; González A; Genescà J
Eur J Clin Invest; 2007 Aug; 37(8):673-8. PubMed ID: 17635579
[TBL] [Abstract][Full Text] [Related]
10. [Hereditary amyloid cardiomyopathy related to a mutation at transthyretin protein number 111. A clinical, genetic and echocardiographic study of an affected Danish family].
Svendsen IH; Steensgaard-Hansen F; Nordvåg BY
Ugeskr Laeger; 1999 Sep; 161(36):4995-9. PubMed ID: 10489791
[TBL] [Abstract][Full Text] [Related]
11. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and origin of amyloid in kidney biopsies.
von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
[TBL] [Abstract][Full Text] [Related]
13. Hereditary amyloid polyneuropathy in north west Ireland.
Staunton H; Dervan P; Kale R; Linke RP; Kelly P
Brain; 1987 Oct; 110 ( Pt 5)():1231-45. PubMed ID: 3676699
[TBL] [Abstract][Full Text] [Related]
14. Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy.
Nelson LM; Penninga L; Villadsen GE; Mølgaard H; Eiskjaer H; Hillingsø JG; Rasmussen A
Clin Transplant; 2015 Dec; 29(12):1098-104. PubMed ID: 26361241
[TBL] [Abstract][Full Text] [Related]
15. Cardiac amyloidosis diagnosed by endomyocardial biopsy. Clinical, histopathological, immunohistochemical and ultrastructural studies.
Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Michalak E; Jakubowska E; Sobieszczańska-Małek M; Deptuch T; Walczak E; Wagner T; Walski M; Rózański J; Kiedrowski M; Lubiszewska B; Hoffman P; Rózyłło W
Kardiol Pol; 2005 Jul; 63(7):20-35. PubMed ID: 16136426
[TBL] [Abstract][Full Text] [Related]
16. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis.
Flodrova P; Flodr P; Pika T; Vymetal J; Holub D; Dzubak P; Hajduch M; Scudla V
Pathology; 2018 Apr; 50(3):261-268. PubMed ID: 29448998
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy.
Li K; Kyle RA; Dyck PJ
Am J Pathol; 1992 Jul; 141(1):217-26. PubMed ID: 1321563
[TBL] [Abstract][Full Text] [Related]
18. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
Sattianayagam PT; Hahn AF; Whelan CJ; Gibbs SD; Pinney JH; Stangou AJ; Rowczenio D; Pflugfelder PW; Fox Z; Lachmann HJ; Wechalekar AD; Hawkins PN; Gillmore JD
Eur Heart J; 2012 May; 33(9):1120-7. PubMed ID: 21992998
[TBL] [Abstract][Full Text] [Related]
19. Secondary systemic amyloidosis: response and survival in 64 patients.
Gertz MA; Kyle RA
Medicine (Baltimore); 1991 Jul; 70(4):246-56. PubMed ID: 2067409
[TBL] [Abstract][Full Text] [Related]
20. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.
Ihse E; Ybo A; Suhr O; Lindqvist P; Backman C; Westermark P
J Pathol; 2008 Oct; 216(2):253-61. PubMed ID: 18729067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
